麻酔科医のためのリスクを有する患者の周術期管理

出版社： 中山書店
著者：
発行日： 2018-05-30
分野： 臨床医学：外科  >  麻酔科学/ペイン
ISBN： 9784521743271
シリーズ： 新戦略に基づく麻酔・周術期医学
電子書籍版： 2018-05-30 （初版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

14,850 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

14,850 円(税込)

購入する

商品紹介

さまざまな疾患や症状などのリスクを有する患者においては，適確な術前評価と麻酔計画が重要となる．
本書では，日常診療で遭遇する頻度が比較的高いリスクを有する患者を取り上げ, 各種麻酔法の選び方や使い方，周術期管理の実際を分かりやすく解説した．また，十分な術前コントロール・評価のできない緊急手術における対応についても実践的な解説を加えた．

目次

  • 1章　リスクを有する患者での麻酔の考え方
    　1-1　吸入麻酔薬の有用性
    　1-2　静脈麻酔薬の有用性
    　1-3　区域麻酔の可能性
    　1-4　困難症例での筋弛緩薬の使い方
    　1-5　オピオイドを使いこなすために
    　1-6　モニタリングをいかに活用するか

    2章　リスクを有する患者の周術期管理の実際
    　2-1　気道確保手技が困難な症例
    　2-2　慢性閉塞性肺疾患（COPD）患者
    　2-3　巨大前縦隔腫瘍
    　2-4　高度心機能低下
    　2-5　たこつぼ型心筋症既往患者
    　2-6　重篤な不整脈を有する患者
    　2-7　心臓移植後の患者
    　2-8　複雑心奇形術後の成人患者
    　2-9　肝不全
    　2-10　肝移植後の患者
    　2-11　慢性腎不全・透析
    　2-12　脊髄損傷患者
    　2-13　脳圧亢進症
    　2-14　筋・神経疾患
    　2-15　重度リウマチ
    　2-16　精神神経疾患
    　2-17　熱傷
    　2-18　褐色細胞腫
    　2-19　長期オピオイド使用中
    　2-20　高度肥満
    　2-21　糖尿病
    　2-22　拒食症・るいそう患者
    　2-23　超高齢者
    　2-24　悪性高熱症の既往や家族歴を有する患者
    　2-25　妊娠中の非産科手術
    　2-26　輸血拒否の患者
    　2-27　静脈血栓塞栓症

    3章　リスクを有する患者の緊急手術での対応
    　3-1　喘息発作中の患者
    　3-2　扁桃摘出術後出血患者
    　3-3　不安定狭心症合併患者
    　3-4　大動脈解離，大動脈瘤
    　3-5　脳動脈瘤
    　3-6　一過性脳虚血発作を生じている患者
    　3-7　急性腎不全患者
    　3-8　バセドウ病
    　3-9　HELLP症候群
    　3-10　敗血症患者
    　3-11　RhD(－) 型血液の患者
    　3-12　抗血栓療法を受けている患者
    　3-13　新生児（非心臓疾患）

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

1章 リスクを有する患者での麻酔の考え方

P.10 掲載の参考文献
1) van Waes JA, et al. One-year mortality, causes of death, and cardiac interventions in patients with postoperative myocardial injury. Anesth Analg 2016 ; 123 : 29-37.
PubMed
2) Hallqvist L, et al. Intraoperative hypotension is associated with myocardial damage in noncardiac surgery : An observational study. Eur J Anaesthesiol 2016 ; 33 : 450-6.
PubMed
3) Kersten JR, et al. Isoflurane mimics ischemic preconditioning via activation of KATP hannels : Reduction of myocardial infarct size with an acute memory phase. Anesthesiology 1997 ; 87 : 361-70.
 
4) De Hert SG, et al. Choice of primary anesthetic regimen can influence intensive care unit length of stay after coronary surgery with cardiopulmonary bypass. Anesthesiology 2004 ; 101 : 9-20.
PubMed
5) Uhlig C, et al. Effects of volatile anesthetics on mortality and postoperative pulmonary and other complications in patients undergoing surgery : A systematic review and meta-analysis. Anesthesiology 2016 ; 124 : 1230-45.
PubMed
6) Fleisher LA, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery : A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 2014 ; 64 : e77-137.
 
7) Yang LQ, et al. The effect of isoflurane or propofol anaesthesia on liver injury after partial hepatectomy in cirrhotic patients. Anaesthesia 2010 ; 65 : 1094-100.
 
8) Beck-Schimmer B, et al. A randomized controlled trial on pharmacological preconditioning in liver surgery using a volatile anesthetic. Ann Surg 2008 ; 248 : 909-18.
PubMed
9) Ko JS, et al. The effects of desflurane and propofol-remifentanil on postoperative hepatic and renal functions after right hepatectomy in liver donors. Liver Transpl 2008 ; 14 : 1150-8.
PubMed
10) 趙成三, 前川拓治. 虚血肝・腎保護作用. 山蔭道明, 平田直之, 編. 吸入麻酔. 東京 : 克誠堂出版 ; 2014. p.163-77.
 
11) Hashiguchi H, et al. Isoflurane protects renal function against ischemia and reperfusion through inhibition of protein kinases, JNK and ERK. Anesth Analg 2005 ; 101 : 1584-9.
PubMed
12) Julier K, et al. Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery : A doubleblinded, placebo-controlled, multicenter study. Anesthesiology 2003 ; 98 : 1315-27.
PubMed
13) Fukazawa K, Lee HT. Volatile anesthetics and AKI : Risks, mechanisms, and a potential therapeutic window. J Am Soc Nephrol 2014 ; 25 : 884-92.
 
14) Reid CW, et al. A comparison of the effects of propofol-alfentanil versus isoflurane anesthesia on arterial oxygenation during one-lung ventilation. J Cardiothorac Vasc Anesth 1996 ; 10 : 860-3.
PubMed
15) Pruszkowski O, et al. Effects of propofol vs sevoflurane on arterial oxygenation during one-lung ventilation. Br J Anaesth 2007 ; 98 : 539-44.
PubMed
16) Schilling T, et al. Effects of volatile and intravenous anesthesia on the alveolar and systemic inflammatory response in thoracic surgical patients. Anesthesiology 2011 ; 115 : 65-74.
PubMed
17) Sun B, et al. Effects of volatile vs. propofol-based intravenous anesthetics on the alveolar inflammatory resposes to one-lung ventilation : A meta-analysis of randomized controlled trials. J Anesth 2015 ; 29 : 570-9.
 
18) Yamakage M, et al. Inhibitory effects of four inhaled anesthetics on canine tracheal smooth muscle contraction and intracellular Ca2+ concentration. Anesth Analg 1993 ; 77 : 67-72.
PubMed
19) Goff MJ, et al. Absence of bronchodilation during desflurane anesthesia : A comparison to sevoflurane and thiopental. Anesthesiology 2000 ; 93 : 404-8.
PubMed
20) Preckel B, et al. Haemodynamic changes during halothane, sevoflurane and desflurane anaesthesia in dogs before and after the induction of severe heart failure. Eur J Anaesthesiol 2004 ; 21 : 797-806.
PubMed
21) Sarkar S, et al. Echocardiographic evaluation and comparison of the effects of isoflurane, sevoflurane and desflurane on left ventricular relaxation indices in patients with diastolic dysfunction. Ann Card Anaesth 2010 ; 13 : 130-7.
PubMed
22) Royse CF, et al. The influence of propofol or desflurane on postoperative cognitive dysfunction in patients undergoing coronary artery bypass surgery. Anaesthesia 2011 ; 66 : 455-64.
PubMed
23) Geng YJ, et al. Effect of propofol, sevoflurane, and isoflurane on postoperative cognitive dysfunction following laparoscopic cholecystectomy in elderly patients : A randomized controlled trial. J Clin Anesth 2017 ; 38 : 165-71.
PubMed
24) Rortgen D, et al. Comparison of early cognitive function and recovery after desflurane or sevoflurane anaesthesia in the elderly : A double blinded randomized controlled trial. Br J Anaesth 2010 ; 104 : 167-74.
PubMed
25) Zhang B, et al. The effects of isoflurane and desflurane on cognitive function in humans. Anesth Analg 2012 ; 114 : 410-5.
PubMed
26) Wigmore TJ, et al. Long-term survival for patients undergoing volatile versus IV anesthesia for cancer surgery : A retrospective analysis. Anesthesiology 2016 ; 124 : 69-79.
PubMed
P.22 掲載の参考文献
1) Pandit JJ, Cook TM, eds. Accidental Awareness during General Anaesthesia in the United Kingdom and Ireland NAP5 Report, Chapter 18 Total intravenous anaesthesia. http://www.nationalauditprojects.org.uk/NAP5report#pt (accessed on August 2nd, 2017)
 
2) Hughes MA, et al. Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthetic drugs. Anesthesiology 1992 ; 76 : 334-41.
PubMed
3) Bouillon T, et al. A model of the ventilatory depressant potency of remifentanil in the non-steady state. Anesthesiology 2003 ; 99 : 779-87.
 
4) 木山秀哉. ke0の謎に迫る. LiSA 2013 ; 20 : 1056-62.
 
5) 木山秀哉. 薬物動態パラメータって何? 森本康裕, 編. 周術期管理の謎 22. 東京 : 克誠堂出版 ; 2015. p.95-113.
 
6) Minto CF, et al. Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development. Anesthesiology 1997 ; 86 : 10-23.
PubMed
7) Morris C, et al. Anaesthesia in haemodynamically compromised emergency patients : Does ketamine represent the best choice of induction agent? Anaesthesia 2009 ; 64 : 532-9.
PubMed
8) Persson J. Wherefore ketamine? Curr Opin Anaesthesiol 2010 ; 23 : 455-60.
PubMed
P.29 掲載の参考文献
1) Liu SS, et al. A comparison of regional versus general anesthesia for ambulatory anesthesia : A meta-analysis of randomized controlled trials. Anesth Analg 2005 ; 101 : 1634-42.
 
2) Modig J. Influence of regional anesthesia, local anesthetics, and sympathicomimetics on the pathophysiology of deep vein thrombosis. Acta Chir Scand Suppl 1989 ; 550 : 119-24 ; discussion 124-7.
 
3) Modig J. Regional anaesthesia and blood loss. Acta Anaesthesiol Scand Suppl 1988 ; 89 : 44-8.
PubMed
4) Fritz BA, et al. Intraoperative electroencephalogram suppression predicts postoperative delirium. Anesth Analg 2016 ; 122 : 234-42.
PubMed
5) Neal JM, et al. Anatomy and pathophysiology of spinal cord injury associated with regional anesthesia and pain medicine : 2015 update. Reg Anesth Pain Med 2015 ; 40 : 506-25.
PubMed
6) Neal JM, et al. The second American society of regional anesthesia and pain medicine evidence-based medicine assessment of ultrasound-guided regional anesthesia : Executive summary. Reg Anesth Pain Med 2016 ; 41 : 181-94.
PubMed
7) Sites BD, et al. Incidence of local anesthetic systemic toxicity and postoperative neurologic symptoms associated with 12,668 ultrasound-guided nerve blocks : An analysis from a prospective clinical registry. Reg Anesth Pain Med 2012 ; 37 : 478-82.
PubMed
8) Vadi MG, et al. Local anesthetic systemic toxicity after combined psoas compartmentsciatic nerve block : Analysis of decision factors and diagnostic delay. Anesthesiology 2014 ; 120 : 987-96.
PubMed
P.35 掲載の参考文献
1) Lacquiere DA, et al. DAS 2015 guidelines for management of CICO. Br J Anaesth 2016 ; 117 : 532-3.
PubMed
2) 日本麻酔科学会. 日本麻酔科学会 気道管理ガイドライン 2014 (日本語訳) -より安全な麻酔導入のために. http://www.anesth.or.jp/guide/pdf/20150427-2guidelin.pdf
 
3) Apfelbaum JL, et al ; American Society of Anesthesiologists Task Force on Management of the Difficult Airway. Practice guidelines for management of the difficult airway : An updated report by the American Society of Anesthesiologists Task Force on Management of the Difficult Airway. Anesthesiology 2013 ; 118 : 251-70.
PubMed
4) Abrishami A, et al. Cochrane corner : Sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade. Anesth Analg 2010 ; 110 : 1239.
PubMed
5) Isono S, et al. Differential effects of vecuronium on diaphragm and geniohyoid muscle in anaesthetized dogs. Br J Anaesth 1992 ; 68 : 239-43.
PubMed
6) Eikermann M, et al. The predisposition to inspiratory upper airway collapse during partial neuromuscular blockade. Am J Respir Crit Care Med 2007 ; 175 : 9-15.
PubMed
7) Fujimoto M, et al. Response to rocuronium and its determinants in patients with myasthenia gravis : A case-control study. Eur J Anaesthesiol 2015 ; 32 : 672-80.
PubMed
8) 日本麻酔科学会. 麻酔薬および麻酔関連薬使用ガイドライン 第3版. VI 筋弛緩薬・拮抗薬. http://www.anesth.or.jp/guide/pdf/publication4-6_20170227s.pdf
 
9) Sugi Y, et al. Restoration of Train-of-Four Ratio with Neostigmine After Insufficient Recovery with Sugammadex in a Patient with Myasthenia Gravis. A A Case Rep 2013 ; 1 : 43-5.
 
10) 富山芳信, ほか. 重症筋無力症患者にロクロニウムとスガマデクスを使用した2症例. 日臨麻会誌 2011 ; 31 : 791-7.
Medical*Online
11) Murphy GS, et al. Residual Neuromuscular Block in the Elderly : Incidence and Clinical Implications. Anesthesiology 2015 ; 123 : 1322-36.
PubMed
12) Cedborg AI, et al. Pharyngeal function and breathing pattern during partial neuromuscular block in the elderly : Effects on airway protection. Anesthesiology 2014 ; 120 : 312-25.
PubMed
13) Stewart PA, et al. The Impact of Residual Neuromuscular Blockade, Oversedation, and Hypothermia on Adverse Respiratory Events in a Postanesthetic Care Unit : A Prospective Study of Prevalence, Predictors, and Outcomes. Anesth Analg 2016 ; 123 : 859-68.
 
14) Rivera R, et al. Perioperative drug therapy in elderly patients. Anesthesiology 2009 ; 110 : 1176-81.
PubMed
15) Keens TG, et al. Developmental pattern of muscle fiber types in human ventilatory muscles. J Appl Physiol Respir Environ Exerc Physiol 1978 ; 44 : 909-13.
PubMed
16) Fisher DM, et al. Pharmacokinetics and pharmacodynamics of d-tubocurarine in infants, children, and adults. Anesthesiology 1982 ; 57 : 203-8.
PubMed
17) Hesselmans LF, et al. Development of innervation of skeletal muscle fibers in man : Relation to acetylcholine receptors. Anat Rec 1993 ; 236 : 553-62.
PubMed
18) Hall HZ, Sanes JR. Synaptic structure and development : The neuromuscular junction. Cell 1993 ; 72 : 99-121.
 
19) Wiqvist N, Wahlin A. Effect of succinylcholine on uterine motility. Acta Anaesthesiol Scand 1962 ; 6 : 71-5.
PubMed
20) Abouleish E, et al. Rocuronium (Org 9426) for caesarean section. Br J Anaesth 1994 ; 73 : 336-41.
PubMed
21) Han T, et al. Neuromuscular pharmacodynamics of rocuronium in patients with major burns. Anesth Analg 2004 ; 99 : 386-92.
PubMed
22) Martyn JA, et al. The neuromuscular effects of pancuronium in burned children. Anesthesiology 1983 ; 59 : 561-4.
PubMed
23) Mills AK, Martyn JA. Neuromuscular blockade with vecuronium in paediatric patients with burn injury. Br J Clin Pharmacol 1989 ; 28 : 155-9.
PubMed
24) Waud BE, Waud DR. Interaction of calcium and potassium with neuromuscular blocking agents. Br J Anaesth 1980 ; 52 : 863-6.
PubMed
25) Fuchs-Buder T, et al. Interaction of magnesium sulphate with vecuronium-induced neuromuscular block. Br J Anaesth 1995 ; 74 : 405-9.
PubMed
26) Miller RD, Roderick LL. Diuretic-induced hypokalaemia, pancuronium neuromuscular blockade and its antagonism by neostigmine. Br J Anaesth 1978 ; 50 : 541-4.
PubMed
P.46 掲載の参考文献
1) Gan TJ, et al. Consensus guidelines for the management of postoperative nausea and vomiting. Anesth Analg 2014 ; 118 : 85-113.
PubMed
2) American Society of Anesthesiologists. ASA Physical Status Classification System. https://www.asahq.org/resources/clinical-information/asa-physical-status-classificationsystem
 
3) Rivera R, Antognini JF. Perioperative drug therapy in elderly patients. Anesthesiology 2009 ; 110 : 1176-81.
PubMed
4) Monk TG, et al. Predictors of cognitive dysfunction after major noncardiac surgery. Anesthesiology 2008 ; 108 : 18-30.
PubMed
5) 日本肥満学会. 肥満症診療ガイドライン 2016. 東京 : ライフサイエンス出版 ; 2016.
 
6) Ingrande J, Lemmens HJ. Dose adjustment of anaesthetics in the morbidly obese. Br J Anaesth 2010 ; 105 : 16-23.
 
7) Liu XY, et al. Unidirectional cross-activation of GRPR by MOR1D uncouples itch and analgesia induced by opioids. Cell 2011 ; 147 : 447-58.
PubMed
8) Sakakihara M, et al. Effects of intrathecal κ-opioid receptor agonist on morphineinduced itch and antinociception in mice. Reg Anesth Pain Med 2016 ; 41 : 69-74.
 
9) Hirabayashi M, et al. Prophylactic pentazocine reduces the incidence of pruritus after cesarean delivery under spinal anesthesia with opioids : A prospective randomized clinical trial. Anesth Analg 2017 ; 124 : 1930-4.
PubMed
P.56 掲載の参考文献
1) Fujioka KA, Douville CM. Anatomy and freehand examination techniques. In : Newwell DW, Aaslid R, eds. Transcranial Doppler. New York : Raven Press ; 1992. p.41-9.
 
2) Brain Trauma Foundation ; American Association of Neurological Surgeons ; Congress of Neurological Surgeons. Guidelines for the management of severe traumatic brain injury. J Neurotrauma 2007 ; 24 : S1-106.
 
3) Chesnut RM, et al. A trial of intracranialpressure monitoring in traumatic brain injury. N Engl J Med 2012 ; 367 : 2471-81.
PubMed
4) Cole CD, et al. Total intravenous anesthesia : Advantages for intracranial surgery. Neurosurgery 2007 ; 61 : 369-77.
PubMed
5) Albanese J, et al. Ketamine decreases intracranial pressure and electroencephalographic activity in traumatic brain injury patients during Propofol sedation. Anesthesiology 1997 ; 87 : 1328-34.
PubMed
6) Engelhard K, Werner C. Inhalational or intravenous anesthetics for craniotomies? Pro inhalational. Curr Opin Anaesthesiol 2006 ; 19 : 504-8.
 
7) Mahla M, et al. Neurologic monitoring. In : Miller RD, ed. Miller's Anesthesia. 6th ed. Philadelphia : Elsevier, Churchill Livingstone ; 2005. p.1511-50. 武田純三, 監修. 稲田英一, ほか監訳. ミラー麻酔科学. 原著第6版. 東京 : メディカル・サイエンス・インターナショナル ; 2007. p.1179-209.
 
8) Chong CT, et al. Direct comparison of the effect of desflurane and sevoflurane on intraoperative motor-evoked potentials monitoring. J Neurosurg Anesthesiol 2014 ; 26 : 306-12.
PubMed
9) Malcharek MJ, et al. Transcranial motor evoked potentials during anesthesia with desflurane versus Propofol--A prospective randomized trial. Clin Neurophysiol 2015 ; 126 : 1825-32.
PubMed
10) Banoub, et al. Pharmacologic and physiologic influences affecting sensory evoked potentials : Implications for perioperative monitoring. Anesthesiology 2003 ; 99 : 716-37.
PubMed
11) Mahmoud M, et al. Susceptibility of transcranial electric motor-evoked potentials to varying targeted blood levels of dexmedetomidine during spine surgery. Anesthesiology 2010 ; 112 : 1364-73.
PubMed
12) Sakamoto T, et al. The effect of hypothermia on myogenic motor-evoked potentials to electrical stimulation with a single pulse and a train of pulses under propofol/ketamine/fentanyl anesthesia in rabbits. Anesth Analg 2003 ; 96 : 1692-7.
 

2章 リスクを有する患者の周術期管理の実際

P.64 掲載の参考文献
1) 磯野史朗. 上気道・気道維持. 磯野史朗, 編. 麻酔科医として必ず知っておきたい周術期の呼吸管理-解剖生理から気道評価・管理, 抜管トラブル, 呼吸器系合併症の対策まで. 東京 : 羊土社 ; 2017. p.22-32.
 
2) Japanese Society of Anesthesiologists. JSA airway management guideline 2014 : To improve the safety of induction of anesthesia. J Anesth 2014 ; 28 : 482-93.
PubMed
3) Langeron O, et al. Prediction of difficult mask ventilation. Anesthesiology 2000 ; 92 : 1229-36.
PubMed
4) Kheterpal S, et al. Prediction and outcomes of impossible mask ventilation : A review of 50,000 anesthetics. Anesthesiology 2009 ; 110 : 891-7.
PubMed
5) Chung F, et al. STOP questionnaire : A tool to screen patients for obstructive sleep apnea. Anesthesiology 2008 ; 108 : 812-21.
PubMed
6) 田垣内祐吾. 抜管前後の上気道機能評価. 磯野史朗, 編. 麻酔科医として必ず知っておきたい周術期の呼吸管理-解剖生理から気道評価・管理, 抜管トラブル, 呼吸器系合併症の対策まで. 東京 : 羊土社 ; 2017. p.204-9.
 
P.72 掲載の参考文献
1) 日本呼吸器学会COPDガイドライン第4版作成委員会, 編. COPD (慢性閉塞性肺疾患) 診断と治療のためのガイドライン 第4版. 東京 : メディカルレビュー社 ; 2013.
 
2) Aubier M, et al. Central respiratory drive in acute respiratory failure of patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1980 ; 122 : 191-9.
PubMed
3) Caroll GC, Rothenberg DM. Carbon dioxide narcosis. Pathological or "pathillogical"? Chest 1992 ; 102 : 986-8.
PubMed
4) Gupta H, et al. Impact of COPD on postoperative outcomes : Results from a national database. Chest 2013 ; 143 : 1599-606.
PubMed
5) Ranieri VM, et al. Physiologic effects of positive end-expiratory pressure in patients with chronic obstructive pulmonary disease during acute ventilatory failure and controlled mechanical ventilation. Am Rev Respir Dis 1993 ; 147 : 5-13.
PubMed
6) Tuxen DV. Detrimental effects of positive end-expiratory pressure during controlled mechanical ventilation of patients with severe airflow obstruction. Am Rev Respir Dis 1989 ; 140 : 5-9.
PubMed
7) Braunlich J, et al. Effects of nasal high flow on ventilation in volunteers, COPD and idiopathic pulmonary fibrosis patients. Respiration 2013 ; 85 : 319-25.
PubMed
P.80 掲載の参考文献
1) 萩平哲. 狭窄気道へのアプローチ. 日臨麻会誌 2010 ; 30 : 727-34.
Medical*Online
2) Azizkhan RG, et al. Life-threatening airway obstruction as a complication to the management of mediastinal masses in children. J Pediatr Surg 1985 ; 20 : 816-22.
 
3) Shamberger RC, et al. Prospective evaluation by computed tomography and pulmonary function tests of children with mediastinal masses. Surgery 1995 ; 118 : 468-71.
PubMed
4) King DR, et al. Pulmonary function is compromised in children with mediastinal lymphoma. J Pediatr Surg 1997 ; 32 : 299-300.
 
5) 植田一吉, ほか. 全身麻酔下で生検手術中にガス交換不全に陥った前縦隔腫瘍の1例. 日臨麻会誌 2003 ; 23 : 276-9.
 
6) 坂口豪, ほか. 全身麻酔が危険であると判断した小児巨大前縦隔腫瘍の3症例. 麻酔 2011 ; 60 : 609-14.
Medical*Online
7) Inoue M, et al. Efficient clinical application of percutaneous cardiopulmonary support for perioperative management of a huge anterior mediastinal tumor. J Thorac Cardiovasc Surg 2006 ; 131 : 755-6.
PubMed
P.85 掲載の参考文献
1) 日本循環器学会. 非心臓手術における合併心疾患の評価と管理に関するガイドライン (2014年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2014_kyo_h.pdf
 
2) Futier E, et al. Effect of indivisualized vs standard blood pressure management strategies on postoperative organ dysfunction among high-risk patients undergoing major surgery : A randomized clinical trial. JAMA 2017 ; 318 : 1346-57.
 
3) Mehta RH, et al. Levosimendan in patients with left ventricular dysfunction undergoing cardiac surgery. N Engl J Med 2017 ; 376 : 2032-42.
PubMed
P.90 掲載の参考文献
1) 佐藤光, ほか. 多枝spasmにより特異な左室造影「ツボ型」を示したstunned myocardium. 児玉和久, ほか編. 臨床からみた心筋細胞障害-虚血から心不全まで. 東京 : 科学評論社 ; 1990. p.56-64.
 
2) Bybee KA, et al. Systematic review : Transient left ventricular apical ballooning : A syndrome that mimics ST-segment elevation myocardial infarction. Ann Intern Med 2004 ; 141 : 858-65.
PubMed
3) Prasad A, et al. Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy) : A mimic of acute myocardial infarction. Am Heart J 2008 ; 155 : 408-17.
 
4) Templin C, et al. Clinical features and outcomes of takotsubo (stress) cardiomyopathy. N Engl J Med 2015 ; 373 : 929-38.
PubMed
5) Kosuge M, et al. Differences in negative T waves between takotsubo cardiomyopathy and reperfused anterior acute myocardial infarction. Circ J 2012 ; 76 : 462-8.
PubMed
6) Weiner M, et al. Takotsubo cardiomyopathy : A clinical update for the cardiovascular anesthesiologist. J Cardiothorac Vasc Anesth 2017 ; 31 : 334-44.
PubMed
P.101 掲載の参考文献
1) Fleisher LA, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery : A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014 ; 130 : e278-333.
 
2) 日本循環器学会. 不整脈の非薬物治療ガイドライン (2011年改訂版). www.j-circ.or.jp/guideline/pdf/JCS2011_okumura_h.pdf
 
3) 日本循環器学会. 不整脈薬物治療に関するガイドライン (2009年改訂版). www.j-circ.or.jp/guideline/pdf/JCS2009_kodama_h.pdf
 
4) 日本循環器学会. 心房細動治療 (薬物) ガイドライン (2013年改訂版). www.j-circ.or.jp/guideline/pdf/JCS2013_inoue_h.pdf
 
5) Kies SJ, et al. Anesthesia for patients with congenital long QT syndrome. Anesthesiology 2005 ; 102 : 204-10.
PubMed
6) Kloesel B, et al. Anesthetic management of patients with Brugada syndrome : A case series and literature review. Can J Anaesth 2011 ; 58 : 824-36.
PubMed
7) Cordery R, et al. Brugada syndrome and anesthetic management. J Cardiothorac Vasc Anesth 2006 ; 20 : 407-13.
PubMed
8) Antzelevitch C, Yan GX. J wave syndrome. Heart Rhythm 2010 ; 7 : 549-58.
PubMed
9) Ota C, et al. Prevalence and prognostic value of early repolarization in low risk surgical patients. Biomed Res Int 2015 ; 2015 : 309260.
PubMed
10) Junttila MJ, et al. Induced Brugada-type electrocardiogram, a sign for imminent malignant arrhythmias. Circulation 2008 ; 117 : 1890-3.
PubMed
11) Fontaine G, et al. Stimulation studies ans epicardial mapping in ventricular tachycardia : Study of mechanisms and selection for surgery. In : Kulbertus HE, ed. Re-entrant Arrhtymias : Mechanism and Treatment. Lancaster MTP Press Limited ; 1977. p.334-50.
 
12) 加藤佳子, 林 行雄. 不整脈原性右室心筋症と麻酔管理. 麻酔 2014 ; 63 : 39-48.
Medical*Online
P.105 掲載の参考文献
1) 戸田宏一, ほか. 心臓移植における長期成績とその問題点. 移植 2016 ; 51 : 324-30.
Medical*Online
2) Herborn J, Parulkar S, et al. Anesthetic considerations in transplant recipients for nontransplant surgery. Anesthesiol Clin 2017 ; 35 : 539-53.
PubMed
3) Birati EY, Rame JE, et al. Post-heart transplant complications. Crit Care Clin 2014 ; 30 : 629-37.
PubMed
4) 林行雄. 移植心を持つ患者の麻酔管理. 日本臨床麻酔学会誌 2001 ; 21 : 300-3.
 
5) Holmes TR, et al. Cardiac surgery is successful in heart transplant recipients. Heart Lung Circ 2014 ; 23 : 703-10.
PubMed
P.115 掲載の参考文献
1) Shiina Y, et al. Prevalence of adult patients with congenital heart disease in Japan. Int J Cardiol 2011 ; 146 : 13-6.
PubMed
2) Toyoda T, et al. Nationwide survey of care facilities for adults with congenital heart disease in Japan. Cir J 2009 ; 73 : 1147-50.
 
3) Mascio CE, et al. Outcomes in adult congenital heart surgery : Analysis of the Society of Thoracic Surgeons database. J Thorac Cardiovasc Surg 2011 ; 142 : 1090-97.
 
4) Fuller SM, et al. Estimating mortality risk for adult congenital heart surgery : An analysis of the Society of Thoracic Surgeons congenital heart surgery database. Ann Thorac Surg 2015 ; 100 : 1728-35.
 
5) Giamberti A, et al. Morbidity and mortality risk factors in adults with congenital heart disease undergoing cardiac reoperations. Ann Thorac Surg 2009 ; 88 : 1284-9.
PubMed
6) Said SM, Dearani JA. Strategies for high-risk reoperations in congenital heart disease. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2014 ; 17 : 9-21.
PubMed
7) Holst KA, et al. Risk factors and early outcomes of multiple reoperations in adults with congenital heart disease. Ann Thorac Surg 2011 ; 92 : 122-30.
PubMed
8) Kurokawa S, et al. Clinical features and risk assessment for cardiac surgery in adult congenital heart disease : Three years at a single Japanese center. Egyptian Journal of Anaesthesia 2014, 30 : 203-10.
 
9) Maxwell BG, et al. Complications of catheter-based electrophysiology procedures in adults with congenital heart disease : A national analysis. J Cardiothorac Vasc Anesth 2015 ; 29 : 258-64.
PubMed
10) Warnes CA, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease : A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 2008 ; 52 : e143-263.
 
11) Maxwell BG, et al. Perioperative outcomes of major noncardiac surgery in adults with congenital heart disease. Anesthesiology 2013 ; 119 : 762-9.
PubMed
12) Norozi K, et al. Incidence and risk distribution of heart failure in adolescents and adults with congenital heart disease after cardiac surgery. Am J Cardiol 2006 ; 97 : 1238-43.
PubMed
13) Diller GP, et al. Exercise intolerance in adult congenital heart disease. Comparative severity, correlates, and prognostic implication. Circulation 2005 ; 112 : 828-35.
PubMed
14) Kempny A, et al. Reference values for exercise limitations among adults with congenital heart disease. Relation to activities of daily life -- single centre experience and review of published data. Eur Heart J 2012 ; 33 : 1386-96.
PubMed
15) Inuzuka R, et al. Comprehensive use of cardiopulmonary exercise testing identifies adults with congenital heart disease at increased mortality risk in the medium term. Circulation 2012 ; 125 : 250-9.
PubMed
16) 黒川智. 成人先天性心疾患患者の麻酔管理 : 心臓麻酔. Cardiovascular Anesthesia 2012 ; 16 : 49-58.
 
17) Bolger AP, et al. Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation 2002 ; 106 : 92-9.
PubMed
18) Dimopoulos K, et al. Prevalence, predictors, and prognostic value of renal dysfunction in adults with congenital heart disease. Circulation 2008 ; 117 : 2320-8.
PubMed
19) Dimopoulos K, et al. Anemia in adults with congenital heart disease relates to adverse outcome. J Am Coll Cardiol 2009 ; 54 : 2093-100.
PubMed
P.121 掲載の参考文献
1) Bernal W, Wendon J. Acute liver failure. N Engl J Med 2013 ; 369 : 2525-34.
PubMed
2) Bernal W, et al. Acute-on-chronic liver failure. Lancet 2015 ; 386 : 1576-87.
PubMed
3) Kaibori M, et al. Usefulness of Tc-99m-GSA scintigraphy for liver surgery. Ann Nucl Med 2011 ; 25 : 593-602.
PubMed
4) Fagundes C, Gines P. Hepatorenal syndrome : A severe, but treatable, cause of kidney failure in cirrhosis. Am J Kidney Dis 2012 ; 59 : 874-85.
PubMed
5) Montano-Loza AJ. Clinical relevance of sarcopenia in patients with cirrhosis. World J Gastroenterol 2014 ; 20 : 8061-71.
PubMed
6) Yates SG, et al. How do we transfuse blood components in cirrhotic patients undergoing gastrointestinal procedures? Transfusion 2016 ; 56 : 791-8.
PubMed
7) Moon AM, et al. Use of antibiotics among patients with cirrhosis and upper gastrointestinal bleeding is associated with reduced mortality. Clin Gastroenterol Hepatol 2016 ; 14 : 1629-37.
PubMed
8) Neal JM, et al. The Second American Society of Regional Anesthesia and Pain Medicine Evidence-Based Medicine Assessment of Ultrasound-Guided Regional Anesthesia : Executive Summary. Reg Anesth Pain Med 2016 ; 41 : 181-94.
PubMed
9) Rahimzadeh P, et al. Anesthesia for patients with liver disease. Hepat Mon 2014 ; 14 : e19881.
PubMed
10) Fujita A, et al. Rapid reversal of neuromuscular blockade by sugammadex after continuous infusion of rocuronium in patients with liver dysfunction undergoing hepatic surgery. Acta Anaesthesiol Taiwan 2014 ; 52 : 54-8.
PubMed
11) Correa-Gallego C, et al. Goal-directed fluid therapy using stroke volume variation for resuscitation after low central venous pressure-assisted liver resection : A randomized clinical trial. J Am Coll Surg 2015 ; 221 : 591-601.
PubMed
12) Richardson AJ, et al. Use of pre-operative steroids in liver resection : A systematic review and meta-analysis. HPB (Oxford) 2014 ; 16 : 12-9.
PubMed
13) Qadan M, et al. Management of postoperative hepatic failure. Am Coll Surg 2016 ; 222 : 195-208.
PubMed
14) Jin S, et al. Management of post-hepatectomy complications. World J Gastroenterol 2013 ; 19 : 7983-91.
 
15) Kunutsor SK, et al. Liver enzymes and risk of all-cause mortality in general populations : A systematic review and meta-analysis. Int J Epidemiol 2014 ; 43 : 187-201.
PubMed
16) Bredt LC, Peres LAB. Risk factors for acute kidney injury after partial hepatectomy. World J Hepatol 2017 ; 9 : 815-22.
PubMed
17) Mirici-Cappa F, et al. How albumin administration for cirrhosis impacts on hospital albumin consumption and expenditure. World J Gastroenterol 2011 ; 17 : 3479-86.
PubMed
P.130 掲載の参考文献
1) Egawa H, et al. Current status of organ transplantation in Japan. Am J Transplant 2012 ; 12 : 523-30.
PubMed
2) Perilli V, et al. Anaesthesiological strategies to improve outcome in liver transplantation recipients. Eur Rev Med Pharmacol Sci 2016 ; 20 : 3172-7.
PubMed
3) Selvaggi G, Tzakis A. Surgical considerations in liver transplantation : Small for size syndrome. Panminerva Med 2009 ; 51 : 227-33.
PubMed
4) Jawan B, et al. Review of anesthesia in liver transplantation. Acta Anaesthesiol Taiwan 2014 ; 52 : 185-96.
PubMed
5) Raut V, Uemoto S. Management of ABO-incompatible living-donor liver transplantation : Past and present trends. Surg Today 2011 ; 41 : 317-22.
PubMed
6) Chavarria L, Cordoba J. Encephalopathy and liver transplantation. Metab Brain Dis 2013 ; 28 : 285-92.
PubMed
7) Kim JM, et al. Central nervous system complications after liver transplantation. J Clin Neurosci 2015 ; 22 : 1355-9.
PubMed
8) Annema C, et al. Trajectories of anxiety and depression after liver transplantation as related to outcomes during 2-year follow-up : A prospective cohort study. Psychosom Med 2017 Nov 7.
 
9) Dehghani SM, et al. Tacrolimus related hypertrophic cardiomyopathy in liver transplant recipients. Arch Iran Med 2010 ; 13 : 116-9.
PubMed
10) Neal DA, et al. Mechanisms of hypertension after liver transplantation. Transplantation 2005 ; 79 : 935-40.
PubMed
11) Huo TI, et al. Proposal of a modified Child-Turcotte-Pugh scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosis. Liver Transpl 2006 ; 12 : 65-71.
PubMed
12) Regelmann MO, et al. New-onset diabetes mellitus after pediatric liver transplantation. Pediatr Transplant 2015 ; 19 : 452-9.
 
13) Moghadamyeghaneh Z, et al. A nationwide analysis of re-exploration after liver transplant. HPB (Oxford) 2017 Nov 9.
PubMed
14) Ersoy Z, et al. Anesthetic and Perioperative Management of Nontransplant Surgery in Patients After Liver Transplant. Exp Clin Transplant 2017 ; 15 (Suppl 1) : 42-5.
 
15) Kostopanagiotou G, et al. Anaesthetic and perioperative management of paediatric organ recipients in nontransplant surgery. Paediatr Anaesth 2003 ; 13 : 754-63.
PubMed
16) Moaveni DM, et al. Anesthetic considerations for the parturient after solid organ transplantation. Anesth Analg 2016 ; 123 : 402-10.
PubMed
P.135 掲載の参考文献
1) 日本透析医学会. 2015年末の慢性透析患者に関する基礎集計. 図説わが国の慢性透析療法の現況 2015年12月31日現在. 東京 : 日本透析医学会 ; 2016. p.2-29.
 
2) Trainor D, et al. Perioperative management of the hemodialysis patient. Semin Dial 2011 ; 24 : 314-26.
PubMed
3) Martin JL, Njoku DB. Understanding the metabolism and toxicity of modern inhaled anesthetics. In : Miller RD, ed. Miller's Anesthesia. 6th ed. Philadelphia : Elsevier Churchill Livingstone ; 2005. 現代の吸入麻酔薬の代謝と毒性. 武田純三, 監修. 稲田英一, ほか監訳. ミラー麻酔科学. 原著第6版. 東京 : メディカル・サイエンス・インターナショナル ; 2007. p.183-215.
 
4) Fukuda K. Opioids. In : Miller RD, ed. Miller's Anesthesia. 6th ed. Philadelphia : Elsevier Churchill Livingstone ; 2005. オピオイド. 武田純三, 監修. 稲田英一, ほか監訳. ミラー麻酔科学. 原著第6版. 東京 : メディカル・サイエンス・インターナショナル ; 2007. p.301-47.
 
5) 日本麻酔科学会. 局所麻酔薬. 麻酔薬および麻酔関連薬使用ガイドライン. 第3版4訂. 東京 : 日本麻酔科学会 ; 2017. p.123-40.
 
6) 沼澤理絵, ほか. 透析患者998症例における麻酔関連危機的偶発症. 透析会誌 2007 ; 40 : 351-9.
 
P.140 掲載の参考文献
1) Schonwald G, et al. Cardiovascular complications during anesthesia in chronic spinal cord injured patients. Anesthesiology 1981 ; 55 : 550-8.
PubMed
2) 横溝由美子, ほか. 自律神経過反射により小脳出血を起こした頸髄損傷者の1例. 泌尿器科紀要 2010 ; 56 : 659-61.
 
3) Hambly PR, Martin B. Anesthesia for chronic spinal cord lesions. Anaesthesia 1998 ; 53 : 273-89.
PubMed
4) 長谷徹太郎, 森本裕二. 脊髄損傷と麻酔管理. 臨床麻酔 2012 ; 36 : 1318-26.
Medical*Online
5) 肺血栓塞栓症/深部静脈血栓症 (静脈血栓塞栓症) 予防ガイドライン作成委員会. 肺血栓塞栓症/深部静脈血栓症 (静脈血栓塞栓症) 予防ガイドライン. http://www.medicalfront.bit/html/06_books/01_guideline/
 
6) Crosby ET. Airway management in adults after cervical spine trauma. Anesthesiology 2006 ; 104 : 1293-318.
PubMed
7) 小寺厚志, ほか. 慢性期高位脊髄損傷患者における自律神経反射亢進に対してレミフェンタニルを使用した1例. 日本臨床麻酔学会誌 2010 ; 30 : 485-9.
Medical*Online
8) Takatsuki A, Ohtsuka M. Clinical trial of a method for confirming the effects of spinal anesthesia in patients with spinal cord injury. J Anesth 2012 ; 26 : 914-7.
PubMed
P.145 掲載の参考文献
1) Steiner LA, Andrews PJD. Monitoring the injured brain : ICP and CBF. Br J Anaesth 2006 ; 97 : 26-38.
PubMed
2) Hawthorne C, Piper I. Monitoring of intracranial pressure in patients with traumatic brain injury. Front Neurol 2014 ; 5 : 121.
PubMed
3) Cole CD, et al. Total intravenous anesthesia : Advantages for intracranial surgery. Neurosurgery 2007 ; 61 : 369-78.
PubMed
4) Engelhard K, Werner C. Inhalational or intravenous anesthetics for craniotomies? Pro inhalational. Curr Opin Anaesthesiol 2006 ; 19 : 504-8.
 
5) Poldermans D, et al. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery. Eur Heart J 2009 ; 30 : 2769-812.
PubMed
6) Brain Trauma Foundation ; American Association of Neurological Surgeons ; Congress of Neurological Surgeons. Guidelines for the management of severe traumatic brain injury. III. Prophylactic hypothermia. J Neurotrauma 2007 ; 24 : S21-5.
 
P.151 掲載の参考文献
1) 日本神経学会, 監修. 「重症筋無力症診療ガイドライン」作成委員会, 編. 重症筋無力症診療ガイドライン 2014. 東京 : 南江堂 ; 2014.
 
2) Kadota Y, et al. Perioperative management in myasthenia gravis : Republication of a systematic review and a proposal by the guideline committee of the Japanese Association for Chest Surgery 2014. Gen Thorac Cardiovasc Surg 2015 : 63 : 201-15,
 
3) Munsat TL. Anticholinesterase abuse in myasthenia gravis. J Neurol Sci 1984 ; 64 (1) : 5-10.
PubMed
4) Zielinski M, et al. Safety for preoperative use of steroids for transsternal thymectomy in myasthenia gravis. Eur J Cardiothorac Surg 2004 ; 26 : 407-11.
PubMed
5) Hirsch NP. Neuromuscular junction in health and disease. Br J Anaesth 2007 ; 99 : 132-8.
PubMed
6) Abel M, Eisenkraft JB. Anesthetic implications of myasthenia gravis. Mt Sinai J Med 2002 ; 69 : 31-7.
PubMed
7) Eisenkraft JB, et al. Resistance to succinylcholine in myasthenia gravis : A dose-response study. Anesthesiology 1988 ; 69 : 760-3.
PubMed
8) Baraka A, et al. Repeated doses of suxamethonium in the myasthenic patient. Anaesthesia 1993 ; 48 : 782-4.
PubMed
9) Fujimoto M, et al. Response to rocuronium and its determinants in patients with myasthenia gravis : A case-control study. Eur J Anaesthesiol 2015 ; 32 (10) : 672-80.
PubMed
10) 日本麻酔科学会. 麻酔薬および麻酔関連薬使用ガイドライン第3版. VI 筋弛緩薬・拮抗薬. http://www.anesth.or.jp/guide/pdf/publication4-6_20170227s.pdf
 
11) Bacchetta MD, et al. Comparison of open versus bedside percutaneous dilatational tracheostomy in the cardiothoracic surgical patient : Outcomes and financial analysis. Ann Thorac Surg 2005 ; 79 (6) : 1879-85.
PubMed
12) 日本神経学会, ほか監修. 「デュシェンヌ型筋ジストロフィー診療ガイドライン」作成委員会, 編. デュシェンヌ型筋ジストロフィー診療ガイドライン 2014. 東京 : 南江堂 ; 2014.
 
13) Takaso M, et al. Surgical management of severe scoliosis with high-risk pulmonary dysfunction in Duchenne muscular dystrophy. Int Orthop 2010 ; 34 : 401-6.
PubMed
14) Schmidt GN, et al. Acute heart failure during spinal surgery in a boy with Duchenne muscular dystrophy. Br J Anaesth 2003 ; 90 : 800-4.
 
15) Iannaccone ST, et al. Postoperative malnutrition in Duchenne muscular dystrophy. J Child Neurol 2003 ; 18 : 17-20.
PubMed
16) Breucking E, et al. Anesthetic complications. The incidence of severe anesthetic complications in patients and families with progressive muscular dystrophy of the Duchenne and Becker types. Anaesthesist 2000 ; 49 : 187-95.
 
17) Yemen TA, McClain C. Muscular dystrophy, anesthesia and the safety of inhalational agents revisited ; Again. Paediatr Anaesth 2006 ; 16 : 105-8.
PubMed
18) Larsen UT, et al. Complications during anaesthesia in patients with Duchenne's muscular dystrophy (a retrospective study). Can J Anaesth 1989 : 36 : 418-22.
PubMed
19) Schmidt J, et al. Onset and duration of mivacurium-induced neuromuscular block in patients with Duchenne muscular dystrophy. Br J Anaesth 2005 ; 95 : 769-72.
PubMed
20) Yamada M, Kimura T. Successful use of sugammadex in a muscular dystrophy patient. Masui 2011 ; 60 : 1205-6.
 
21) Kono Y, et al. Anesthetic management for a patient with multiple sclerosis. Masui 2005 ; 54 : 906-8.
PubMed
22) Jones RM, Healy TE. Anaesthesia and demyelinating disease. Anaesthesia 1980 ; 35 : 879-84.
PubMed
23) 濱田宏, 河本昌志. 特殊な病態下での筋弛緩薬の使い方. 岩崎寛, 編. 筋弛緩薬. 東京 : 克誠堂 ; 2010. p.299-300.
 
24) Wachi M, et al. Use of sugammadex in a patient with amyotrophic lateral sclerosis. Masui 2011 ; 60 : 1408-10.
 
P.160 掲載の参考文献
1) 西村泰治. 免疫遺伝学. 宮坂信之, 編. 最新膠原病・リウマチ学. 東京 : 朝倉書店 ; 2001. p.25-34.
 
2) ここまで分かった最新のリウマチ免疫異常. http://www.hakatara.net/images/no14/14-1.pdf
 
3) 日本リウマチ財団. リウマチ情報センター. http://www.rheuma-net.or.jp/rheuma/rm400/rm400_shindan.html
 
4) Samanta R, et al. Rheumatoid arthritis and anaesthesia. Anaesthesia 2011 ; 66 : 1146-59.
PubMed
5) Aires RB, et al. Pre-operative anesthetic assessment of patients with rheumatoid arthritis. Rev Bras Reumatol 2014 ; 54 : 213-9.
PubMed
6) Maradit-Kremers H, et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthiritis. A population-based cohort study. Arthritis Rheum 2005 ; 52 : 402-11.
 
7) 日本リウマチ学会, 監修. 第2章 関節リウマチ診療ガイドライン 2014. http://minds.jcqhc.or.jp/n/med/4/med0064/G0000706/0001
 
8) 日本リウマチ財団. 治療ガイドライン. http://www.rheuma-net.or.jp/rheuma/common_box/publications/pdf/guideline1to4.pdf
 
9) Coursin DB, Wood KE. Corticosteroid supplementation for adrenal insufficiency. JAMA 2002 ; 287 : 236-40.
PubMed
P.173 掲載の参考文献
1) 日本精神神経学会精神科病名検討連絡会. DSM-5 病名・用語翻訳ガイドライン (初版). 精神神経学雑誌 2014 ; 116 : 429-57.
 
2) 小坂美樹, 飯島毅彦. 精神疾患と麻酔. 注意欠如・多動性障害 (ADHD) -メチルフェニデート, アトモキセチンが麻酔薬に及ぼす影響. LiSA 2015 ; 22 : 1234-9.
 
3) 田中康雄. ADHD. 日本医師会雑誌 2013 ; 142 : S323-4.
 
4) Perruchoud C, Chollet-Rivier M. Cardiac arrest during induction of anaesthesia in a child on long-term amphetamine therapy. Br J Anaesth 2008 ; 100 : 421-2.
 
5) 日本精神神経学会. 統合失調症とは何か. https://www.jspn.or.jp/modules/activity/index.php?content_id=79
 
6) 山口大樹, 水野雅文. 統合失調症. 神経・精神疾患診療マニュアル. 日本医師会雑誌 2013 ; 142 : S305-6.
 
7) 鈴木昭仁, 大谷浩一. 精神科薬物療法. 神経・精神疾患診療マニュアル. 日本医師会雑誌 2013 ; 142 : S348-51.
 
8) 工藤明. 統合失調症. 麻酔前の評価・準備と予後予測 II. 麻酔 2010 ; 59 : 1105-15.
 
9) Kudoh A. Perioperative management for chronic schizophrenic patiens. Anesth Analg 2005 ; 101 : 1867-72.
 
10) 北條亜樹子, ほか. 統合失調症-麻酔で幻覚を見ることはありません. LiSA 2015 ; 22 : 1206-10.
 
11) Bajwa SJS, et al. Psychiatric diseases : Need for an increased awareness among the anesthesiologists. J Anaesthesiol Clin Pharmacol 2011 ; 27 : 440-6.
PubMed
12) Attri JP, et al. Psychiatric patient and anaesthesia. Indian J Anaesth 2012 ; 56 : 8-13.
PubMed
13) 加藤正樹. 双極性障害. 神経・精神疾患診療マニュアル. 日本医師会雑誌 2013 ; 142 : S287-8.
 
14) 日本うつ病学会 気分障害の治療ガイドライン作成委員会. 日本うつ病学会治療ガイドライン I. 双極性障害 2012. http://www.secretariat.ne.jp/jsmd/mood_disorder/img/120331.pdf
 
15) 渡部真也, ほか. うつ病. 神経・精神疾患診療マニュアル. 日本医師会雑誌 2013 ; 142 : S284-6.
 
16) 工藤明. うつ病. 麻酔前の評価・準備と予後予測 II. 麻酔 2010 ; 59 : 1116-27.
 
17) 工藤明. うつ病-うつ病患者の麻酔にはケタミンを用いるのも一考. LiSA 2015 ; 22 : 1202-5.
 
18) Ghoneim MM, O'Hara MW. Depression and postoperative complications : An overview. BMC Surg 2016 ; 16 : 1-10.
 
19) 医薬品医療機器総合機構. セロトニン症候群. 重篤副作用疾患別対応マニュアル. https://www.pmda.go.jp/files/000144659.pdf
 
20) 八田耕太郎. パニック障害. 神経・精神疾患診療マニュアル. 日本医師会雑誌 2013 ; 142 : S301-2.
 
21) 玉岡晃. アルツハイマー病. 神経・精神疾患診療マニュアル. 日本医師会雑誌 2013 ; 142 : S192-4.
 
22) 合谷木徹. 術後認知機能障害. 横山正尚, 編. 麻酔科医のための周術期危機管理と合併症への対応. 新戦略に基づく麻酔・周術期医学. 東京 : 中山書店 ; 2016. p.274-80.
 
23) 下泰司, 服部信孝. パーキンソン病. 神経・精神疾患診療マニュアル. 日本医師会雑誌 2013 ; 142 : S205-7.
 
24) 村田裕, ほか. Parkinson病-多彩な症状と投薬内容に対処する. LiSA 2015 ; 22 : 1212-6.
 
25) 日本神経学会. 第II編 クリニカル・クエスチョン. 第1章 治療総論. パーキンソン病治療ガイドライン 2011. https://www.neurology-jp.org/guidelinem/pdgl/sinkei_pdgl_2011_11.pdf
 
P.181 掲載の参考文献
1) 日本熱傷学会. 熱傷診療ガイドライン 改訂第2版. http://www.jsbi-burn.org/members/guideline/pdf/guideline2.pdf
 
2) 日本皮膚科学会. 創傷・褥瘡・熱傷ガイドライン-6 : 熱傷診療ガイドライン. https://www.dermatol.or.jp/uploads/uploads/files/熱傷診療ガイドライン.pdf
 
3) Wolter TP, et al. Is high PEEP low volume ventilation in burn patients beneficial? A retrospective study of 61 patients. Burns 2004 ; 30 : 368-73.
PubMed
4) Masimo. http://www.masimo.com/home/rainbow-pulse-co-oximetry/technology-overview/
 
5) Baxter CR, Shires T. Physiological response to crystalloid resuscitation of severe burns. Ann N Y Acad Sci 1968 ; 150 : 874-94.
 
6) Fakhry SM, et al. Regional and institutional variation in burn care. J Burn Care Rehabil 1995 ; 16 : 86-90 ; discussion 85.
 
7) Powell-Tuck J, et al. British Consensus Guidelines on Intravenous Fluid Therapy for Adult Surgical Patients (GIFTASUP). 2011. http://www.bapen.org.uk/pdfs/bapen_pubs/giftasup.pdf
 
8) Chen ZH, et al. The application of early goal directed therapy in patients during burn shock stage. Int J Burn Trauma 2017 ; 7 : 27-33. http://www.IJBT.org/ISSN:2160-2026/IJBT0057225
 
9) Guilabert P, et al. Fluid resuscitation management in patients with burns : Update. Br J Anaesth 2016 ; 117 : 284-96.
PubMed
10) Barik A, et al. Crosstalk between Agrin and Wnt signaling pathways in development of vertebrate neuromuscular junction. Dev Neurobiol 2014 ; 74 : 828-38.
PubMed
11) Gibson BR, et al. Intensive insulin therapy confers a similar survival benefit in the burn intensive care unit to the surgical intensive care unit. Surgery 2009 ; 146 : 922-30.
 
P.187 掲載の参考文献
1) 成瀬光栄, ほか. 褐色細胞腫の実態および診断基準と診療アルゴニズム. 日外会誌 2012 ; 113 : 378-83.
 
2) Miller RD, ed. Miller's Anesthesia. 7th ed. Philadelphia : Churchill Livingstone ; 2010. p.1067-149.
 
3) 厚生労働省難治性疾患克服研究事業「褐色細胞腫の実態調査と診療指針の作成」研究班, 編. 褐色細胞腫診療指針 2010. 2010.
 
4) 川村幸治, ほか. 副腎腫瘍摘除術の周術期管理. 泌尿器外科 2016 ; 29 : 1551-6.
Medical*Online
5) Grazzini E, et al. Vasopressin receptors in human adrenal medulla and pheochromocytoma. J Clin Endocrinol Metab 1999 ; 84 : 2195-203.
PubMed
6) Pacak K. Preoperative management of the pheochromocytoma patient. J Clin Enndocrinol Metab 2007 ; 92 : 4069-79.
 
7) Plouin PF, et al. Factors associated with perioperative morbidity and mortality in patients with pheochromocytoma : Analysis of 165 operations at a single center. J Clin Endocrinol Metab 2001 ; 86 : 1480-6.
 
8) Lenders JW, et al. Pheochromocytoma and paraganglioma : An endocrine society clinical practice guideline. J Clin Endocrinol Metab 2014 ; 99 : 1915-42.
PubMed
9) 木村美葉, ほか. 褐色細胞腫の麻酔管理中, 循環血液量および血中プロポフォール濃度を測定した1症例. 麻酔 2002 ; 51 : 489-92.
Medical*Online
10) Lenders JW, et al. Phaeochromocytoma. Lancet 2005 ; 366 : 665-75.
PubMed
11) Mallat J, et al. Systolic pressure variation (Deltadown) can guide fluid therapy during pheochromocytoma surgery. Can J Anaesth 2003 ; 50 : 998-1003.
PubMed
12) 金沢晋弥, ほか. 褐色細胞腫摘出後のカテコラミン抵抗性低血圧に低用量バソプレシンが奏効した1症例. 麻酔 2013 ; 62 : 1218-21.
Medical*Online
P.193 掲載の参考文献
1) 山口重樹, ほか. 慢性疼痛に対するオピオイド治療. 臨床麻酔 2016 ; 40 : 169-77.
Medical*Online
2) Rauck RL, et al. Opioid-induced constipation survey in patients with chronic noncancer pain. Pain Pract 2017 ; 17 : 329-35.
PubMed
3) Fletcher D, Martinez V. How can we prevent opioid induced hyperalgesia in surgical patients? Br J Anaesth 2016 ; 116 : 447-79.
PubMed
4) 橋口さおり. オピオイド使用患者における周術期疼痛管理. 臨床麻酔 2014 ; 38 : 775-9.
Medical*Online
5) Wesson DR, Ling W. The clinical opiate withdrawal scale (COWS). J Psychoactive Drugs 2003 ; 35 : 253-9.
PubMed
6) Koo CY, Eikermann M. Respiratory effects of opioids in perioperative medicine. The Open Anesthesiology Journal 2011 ; 5 : S23-34.
 
P.200 掲載の参考文献
1) 日本肥満学会肥満症診療ガイドライン作成委員会, 編. 肥満症診療ガイドライン 2016. 東京 : ライフサイエンス出版 ; 2016.
 
2) 豊田大介, ほか. 高度肥満患者の麻酔管理. 臨床麻酔 2016 ; 40 : 1645-54.
Medical*Online
3) Nightingale CE, et al. Peri-operative management of the obese surgical patient 2015 : Association of Anaesthetists of Great Britain and Ireland Society for Obesity and Baratric Anaesthesia. Anaesthesia 2015 ; 70 : 859-76.
 
4) Varon J, Mark P. Management of the obese critically ill patient. Cri Care Clin 2001 ; 17 : 187-200.
 
5) Specialists in Obesity and Bariatric Anaesthesia. The SOBA Single Sheet Guideline. http://www.sobauk.co.uk/downloads/single-sheet-guideline
 
P.206 掲載の参考文献
1) 日本糖尿病学会. 糖尿病診療ガイドライン 2016. 東京 : 南光堂 ; 2016.
 
2) Sebranek JJ, et al. Glycaemic control in the perioperative period. Br J Anaesth 2013 ; 111 Suppl 1 : i18-34.
 
3) Membership of the Working Party, Barker P, et al. Peri-operative management of the surgical patient with diabetes 2015 : Association of Anaesthetists of Great Britain and Ireland. Anaesthesia 2015 ; 70 : 1427-40.
PubMed
4) Yamasaki K, et al. Effect of intraoperative acetated Ringer's solution with 1% glucose on glucose and protein metabolism. J Anesth 2010 ; 24 : 426-31.
PubMed
5) Buchleitner AM, et al. Perioperative glycaemic control for diabetic patients undergoing surgery. Cochrane Database Syst Rev 2012 ; (9) : CD007315.
PubMed
6) Yatabe T, et al. The optimal target for acute glycemic control in critically ill patients : A network meta-analysis. Intensive Care Med 2017 ; 43 : 16-28.
PubMed
7) Marik PE, Egi M. Treatment thresholds for hyperglycemia in critically ill patients with and without diabetes. Intensive Care Med 2014 ; 40 : 1049-51.
PubMed
P.213 掲載の参考文献
1) Seller CA, Ravalia A. Anaesthetic implications of anorexia nervosa. Anaesthesia 2003 ; 58 : 437-43.
PubMed
2) 宮崎滋. 1. 肥満と肥満症. 日内会誌 2011 ; 100 : 897-902.
 
3) 厚生労働省. 中枢性摂食異常調査研究班全国疫学調査. www.mhlw.go.jp/kokoro/speciality/detail_eat.html
 
4) 厚生労働省難治性疾患克服研究事業「中枢性摂食異常症に関する調査研究班」. 神経性食欲不振症のプライマリケアのためのガイドライン 2007. http://www.edportal.jp/pro/pdf/primary_care_2007.pdf
 
5) 田上哲也, ほか. 中枢性摂食異常症. 医療 2001 ; 55 : 624-7.
Medical*Online
6) Stewart D, et al. Perioperative management of severe anorexia nervosa. Br J Anaesth 2015 ; 114 : 709-10.
PubMed
7) Becker AE, et al. Eating disorders. N Engl J Med 1999 ; 340 : 1092-8.
PubMed
8) Hirose K, et al. Perioperative management of severe anorexia nervosa. Br J Anaesth 2014 ; 112 : 246-54.
PubMed
9) Sandstrom R, et al. The effect of postoperative intravenous feeding (TPN) on outcome following major surgery evaluated in a randomized study. Ann Surg 1993 ; 217 : 185-95.
 
10) Gaudiani JR, et al. Severe anorexia nervosa : Outcomes from a medical stabilization unit. Int J Eat Disord 2012 ; 45 : 85-92.
 
11) 山中学, 久保木富房. I. 症候・検査値からみた内分泌疾患. 7. 肥満・るいそう. 日内会誌 1998 ; 87 : 1028-33.
 
12) Weimann A, et al. ESPEN guideline : Clinical nutrition in surgery. Clin Nutr 2017 ; 36 : 623-50.
 
13) 岩坂日出夫, 田原里美. 栄養不良. 高崎眞弓, ほか編. まれな疾患の麻酔 A to Z. 東京 : 文光堂 ; 2015. p.232.
 
14) 若林秀隆. サルコペニアと栄養療法・高齢者の栄養状態とQOL. 静脈経腸栄養 2014 ; 29 : 837-42.
 
P.220 掲載の参考文献
1) Sieber FE, Pauldine R. 高齢者麻酔. Miller RD, ed. 武田純三, 監修. 稲田英一, ほか監訳. ミラー麻酔科学. 原著第6版. 東京 : メディカル・サイエンス・インターナショナル ; 2007. p.1889-99.
 
2) Pisani M, et al. Days of delirium are associated with 1-year mortality in an older intensive care unit population. Am J Respir Crit Care Med 2009 ; 180 : 1092-7.
 
3) 杉浦昌也. 虚血性心疾患. 内科 1980 ; 46 : 30-5.
 
4) Fleisher LA, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery : A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2007 ; 116 : e418-99.
 
5) Gopaldas RR, et al. Superior nationwide outcomes of endovascular versus open repair for isolated descending thoracic aortic aneurysm in 11,669 patients. J Thorac Cardiovasc Surg 2010 ; 140 : 1001-10.
PubMed
6) Bixler EO, et al. Sleep apneic activity in order healthy subjects. J Appl Physiol 1985 ; 58 : 1597-601.
 
7) Rivera R, Antognini JF. Perioperative drug therapy in elderly patients. Anesthesiology 2009 ; 110 : 1176-81.
PubMed
8) Gerstenblith G, et al. Stress testing redefines the prevalen
 
P.227 掲載の参考文献
1) Rosenberg H, et al. Malignant hyperthermia : A review. Orphanet J Rare Dis 2015 ; 10 : 93.
PubMed
2) 向田圭子, 河本昌志. 悪性高熱症-最近の話題について. 日臨麻会誌 2012 ; 32 : 682-90.
Medical*Online
3) Bendixen D, et al. Analysis of anaesthesia in patients suspected to be susceptible to malignant hyperthermia before diagnostic in vitro contracture test. Acta Anaesthesiol Scand 1997 ; 41 : 480-4.
PubMed
4) Bjorksten AR, et al. Sequencing of genes involved in the movement of calcium across human skeletal muscle sarcoplasmic reticulum : Continuing the search for genes associated with malignant hyperthermia. Anaesth Intensive Care 2016 ; 44 : 762-8.
PubMed
5) Snoeck M, et al. RYR1-related myopathies : A wide spectrum of phenotypes throughout life. Eur J Neurol 2015 ; 22 : 1094-112.
PubMed
6) Schartner V, et al. Dihydropyridine receptor (DHPR, CACNA1S) congenital myopathy. Acta Neuropathol 2017 ; 133 ; 517-33.
PubMed
7) Migita T, et al. Calcium channel blockers are inadequate for malignant hyperthermia crisis. J Anesth 2012 ; 26 : 579-84.
PubMed
8) Haraki T, et al. Mutated p.4894 RyR1 function related to malignant hyperthermia and congenital neuromuscular disease with uniform type 1 fiber (CNMDU1). Anesth Analg 2011 ; 113 : 1461-7.
PubMed
9) Riazi S, et al. Malignant hyperthermia in Canada : Characteristics of index anesthetics in 129 malignant hyperthermia susceptible probands. Anesth Analg 2014 ; 118 : 381-7.
PubMed
10) Barnes C, et al. Safe duration of postoperative monitoring for malignant hyperthermia patients administered non-triggering anaesthesia : An update. Anaesth Intensive Care 2015 ; 43 : 98-104.
PubMed
11) Fiszer D, et al. Next-generation sequencing of RYR1 and CACNA1S in malignant hyperthermia and exertional heat illness. Anesthesiology 2015 ; 122 : 1033-46.
PubMed
P.235 掲載の参考文献
1) Balinskaite V, et al. The risk of adverse pregnancy outcomes following nonobstetric surgery during pregnancy : Estimates from a retrospective cohort study of 6.5 million pregnancies. Ann Surg 2017 ; 266 : 260-6.
PubMed
2) Reitman E, Flood P. Anaesthetic considerations for non-obstetric surgery during pregnancy. Br J Anaesth 2011 ; 107 Suppl 1 : i72-8.
 
3) Graham MR. Clinical update regarding general anesthesia-associated neurotoxicity in infants and children. Curr Opin Anaesthesiol 2017 ; 30 : 682-7.
PubMed
4) Olutoye OA, et al. Food and Drug Administration warning on anesthesia and brain development : Implications for obstetric and fetal surgery. Am J Obstet Gynecol 2017 [Epub ahead of print].
 
5) Gilo NB, et al. Appendicitis and cholecystitis in pregnancy. Clin Obstet Gynecol 2009 ; 52 : 586-96.
PubMed
6) Practice Guidelines for Obstetric Anesthesia : An Updated Report by the American Society of Anesthesiologists Task Force on Obstetric Anesthesia and the Society for Obstetric Anesthesia and Perinatology. Anesthesiology 2016 ; 124 : 270-300.
 
7) Committee on Obstetric Practice and the American Society of Anesthesiologists. Committee Opinion No. 696 : Nonobstetric Surgery During Pregnancy. Obstet Gynecol 2017 ; 129 : 777-8.
 
P.240 掲載の参考文献
1) 千代崎英雄. 問題の整理-「エホバの証人」の輸血忌避は宗教的戒律である. 輸血は罪か-「エホバの証人」の輸血拒否をめぐって. 東京 : いのちのことば社 ; 1987. p.9-16.
 
2) 星野晋. 輸血拒否の主体は誰か-文化人類学的視点から見た輸血拒否. 日臨麻会誌 2006 ; 3 : 296-302.
 
3) 當銘正彦. 「エホバの証人」信徒への診療-その倫理的問題について. 医療コンフリクト・マネジメント 2014 ; 3 : 33-5.
 
4) 花岡一雄. 輸血拒否者の麻酔. 茅稽二, ほか編. 困難な症例に学ぶ最新の臨床麻酔. 東京 : 克誠堂出版 ; 1986. p.389-97.
 
5) 萬知子. エホバの証人. 麻酔 2010 ; 59 : 1149-52.
Medical*Online
6) 宗教的輸血拒否に関する合同委員会報告. 宗教的輸血拒否に関するガイドライン. 2008. http://www.anesth.or.jp/guide/pdf/guideline.pdf
 
7) 奥田泰久. 判例ピックアップ (第8回) 宗教的理由による輸血拒否-患者の意向に従い, 術中に輸血をしなかった. LiSA 2016 ; 23 : 1110-6.
 
P.247 掲載の参考文献
1) 日本麻酔科学会. 2014年JSA肺血栓塞栓症発症調査結果の概要. http://www.anesth.or.jp/med/pdf/kekka_haikessen2014.pdf
 
2) Stein PD, et al. Pulmonary thromboembolism in Asians/Pacific Islanders in the United states : Analysis of date from the National Hospital Discharge Survey and the United States Bureau of the Census. Am J Med 2004 ; 116 : 435-42.
 
3) Klatsky AL, et al. Risk of pulmonary embolism and/or deep venous thrombosis in Asian-Americans. Am J Cardiol 2000 ; 85 : 1334-7.
PubMed
4) 日本循環器学会 (班長 : 安藤太三). 循環器病の診断と治療に関するガイドライン (2008年度合同研究班報告) : 肺血栓塞栓症および深部静脈血栓症の診断, 治療, 予防に関するガイドライン (2009年改訂版). http://wwwj-circ.or.jp/guideline/pdf/JSC2009_andoh_h.pdf
 
5) 北口勝康. I 総論-3症状, 検査, 診断. 瀬尾憲正, 古家仁, 編. 周術期深部静脈血栓症/肺血栓塞栓症. 東京 : 克誠堂出版 ; 2013. p.21-34.
 
6) 長谷川浩一, ほか. 急性肺塞栓症の早期診断と治療対策-多施設225例の臨床的解析. 呼吸と循環 1993 ; 41 : 773-7.
 
7) Nakamura M, et al. Clinical characteristics of acute pulmonary thromboembolism in Japan : Results of a multicenter registry in the Japan Society of Pulmonary Embolism Research. Clin Cardiol 2001 ; 24 : 132-8.
PubMed
8) 黒岩政之. 肺血栓塞栓症. 麻酔 2011 ; 60 増刊号 : s55-68.
 
9) McConnell MV, et al. Regional right ventricular dysfunction detected by echocardiography in acute pulmonary embolism. Am J Cardiol 1996 ; 78 : 469-73.
PubMed

3章 リスクを有する患者の緊急手術での対応

P.257 掲載の参考文献
1) Wu RS, et al. Effects of fenoterol and iparatropium on respiratory resistance of asthmatics after tracheal intubation. Br J Anaesth 2000 ; 84 : 358-62.
PubMed
2) Elwood T, et al. Bronchodilator premedication does not decrease respiratory adverse events in pediatric general anesthesia. Can J Anaesth 2003 ; 50 : 277-84.
 
3) Ballantyne JC, et al. The comparative effects of postoperative analgesic therapies on pulmonary outcome : Cumulative meta-analyses of randomized, controlled trials. Anesth Analg. 1998 ; 86 : 598-612.
PubMed
4) Jayr C, et al. Postoperative pulmonary complications. Epidural analgesia using bupivacaine and opioids versus parenteral opioids. Anesthesiology 1993 ; 78 : 666-76.
PubMed
P.265 掲載の参考文献
1) 生駒亮, ほか. 口蓋扁桃摘出術の術後出血に関する検討-危険因子と対策について. 口腔・咽頭科 2016 ; 29 : 71-5.
Medical*Online
2) Hayes K. Five Year Old Dies After Tonsillectomy. https://www.verywell.com/five-year-old-dies-after-tonsillectomy-3972213
 
3) Windfuhr JP. Lethal post-tonsillectomy hemorrhage. Auris Nasus Larynx 2003 ; 30 : 391-6.
PubMed
4) Windfuhr JP, et al. Lethal outcome of post-tonsillectomy hemorrhage. Eur Arch Otorhinolaryngol 2008 ; 265 : 1527-34.
PubMed
5) Franco RA Jr, et al. First place--resident clinical science award 1999. Quality of life for children with obstructive sleep apnea. Otolaryngol Head Neck Surg 2000 ; 123 : 9-16.
PubMed
6) Iwasaki H, et al. A case series of re-establishment of neuromuscular block with rocuronium after sugammadex reversal. J Anesth 2016 ; 30 : 534-7.
PubMed
7) 鈴木昭広, ほか. 小児の迅速導入におけるエアトラックの有用性. 臨床麻酔 2008 ; 32 : 45-8.
 
8) Lim NL. The use of the laryngeal mask airway in post-tonsillectomy hemorrhage--A case report. Ann Acad Med Singapore 2000 ; 29 : 764-5.
PubMed
9) Hirai T, et al. A Comparison of analgesic effect between loxoprofen and celecoxib and the frequency of the hemorrhage following tonsillectomy. Nippon Jibiinkoka Gakkai Kaiho (Tokyo) 2016 ; 119 : 1110-6.
 
P.270 掲載の参考文献
1) 日本循環器学会 (班長 : 許俊鋭). 非心臓手術における合併心疾患の評価と管理に関するガイドライン (2014年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2014_kyo_h.pdf
 
2) Fleisher LA, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery : A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014 ; 130 : e278-333.
 
3) Kristensen SD, et al. 2014 ESC/ESA Guidelines on non-cardiac surgery : Cardiovascular assessment and management : The Joint Task Force on non-cardiac surgery : Cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J 2014 ; 35 : 2383-431.
 
4) Fleisher LA, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery : A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) : Developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation 2007 ; 116 : e418-99.
 
5) Anderson JL, et al. 2011 WRITING GROUP MEMBERS ; ACCF/AHA TASK FORCE MEMBERS. 2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction : A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011 ; 123 : e426-579.
 
6) 日本循環器学会 (班長 : 木村剛). 非ST上昇型急性冠症候群の診療に関するガイドライン (2012年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2012_kimura_h.pdf
 
P.276 掲載の参考文献
1) 日本循環器学会 (班長 : 許俊鋭). 非心臓手術における合併心疾患の評価と管理に関するガイドライン (2014年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2014_kyo_h.pdf
 
2) 日本循環器学会 (班長 : 高本眞一). 大動脈瘤・大動脈解離診療ガイドライン (2011年改訂版). http://www.j-circ.or.jp/guideline/pdf/JCS2011_takamoto_h.pdf
 
3) Hiratzka LF, et al. American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines ; American Association for Thoracic surgery ; American College of Radiology ; American Stroke Association ; Society of Cardiovascular Anesthesiologists ; Society for Cardiovascular Angiography and Interventions ; Society of Interventional Radiology ; Society of Thoracic Surgeons ; Society for Vascular Medicine. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease : Executive summary : A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicin
 
4) Erbel R, et al. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases : Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart J 2014 ; 35 : 2873-926.
 
P.283 掲載の参考文献
1) White PM, et al. Can noninvasive imaging accurately depict intracranial aneurysms? A systematic review. Radiology 2000 ; 217 : 361-70.
PubMed
2) Asari S, et al. Natural history and risk factors of unruptured cerebral aneurysms. Clin Neurol Neurosurg 1993 ; 95 : 205-14.
PubMed
3) International Study of Unruptured Intracranial Aneurysms (ISUIA) Investigators. Unruptured intracranial aneurysms--Risk of rupture and risks of surgical intervention. N Engl J Med 1998 ; 339 : 1725-33.
 
4) Bederson JB, et al. Recommendations for the management of patients with unruptured intracranial aneurysms : A statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke 2000 ; 31 : 2742-50.
PubMed
5) Yoshimoto T, Mizoi K. Importance of unruptured cerebral aneurysms. Surg Neurol 1997 ; 47 : 522-6.
PubMed
6) Vlak MH, et al. Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period : A systematic review and meta-analysis. Lancet Neurol 2011 ; 10 : 626-36.
PubMed
7) Benzon HA, et al. Pediatric neurovascular lesions. In : Mongan PD, et al, eds. A Practical Approach to Neuroanesthesia. Philadelphia : Lippincott Williams & Wilkins ; 2013. p.262.
 
8) Young BG, et al. An assessment of nonconvulsive seizures in the intensive care unit using continuous EEG monitoring : An investigation of variables associated with mortality. Neurology 1996 ; 47 : 83-9.
 
9) Sonobe M, et al. Small unruptured intracerebral aneurysm verification study : SUAVe Study, Japan. Stroke 2010 ; 41 : 1969-77.
 
10) 山崎友郷, ほか. 未破裂脳動脈瘤の自然経過- SUAVe Studyを含めて. 脳外誌 2012 ; 21 : 288-97.
 
11) The UCAS Japan Investigators. The natural course of unruptured cerebral aneurysms in Japan cohort. N Engl J Med 2012 ; 366 : 2474-82.
 
12) Ujiie H, et al. Hemodynamic study of the anterior communicating artery. Stroke 1996 ; 27 : 2086-93.
PubMed
13) Kim YW, et al. Cerebral aneurysms in pregnancy and delivery : Pregnancy and delivery do not increase the risk of aneurysm rupture. Neurosurgery 2013 ; 72 : 143-9 ; discussion 150.
 
14) Kanani N, Goldszmidt E. Postpartum rupture of an intracranial aneurysm. Obstet Gynecol 2007 ; 109 (2 Pr2) : 572-4.
 
15) Yamashiro S, et al. Improvement of quality of life in patients surgically treated for asymptomatic unruptured intracranial aneurysms. J Neurol Neurosurg Psychiatry 2007 ; 78 : 497-500.
PubMed
16) Suzuki T, et al. Determining the presence of thin-walled regions at high-pressure areas in unruptured cerebral aneurysms by using computational fluid dynamics. Neurosurgery 2016 ; 79 : 589-95.
PubMed
17) Yoshimura Y, et al. Statin use and risk of cerebral aneurysm rupture : A hospital-based case-control study in Japan. J Stroke Cerebrovasc 2014 ; 23 : 343-8.
 
18) Hasan DM, et al. Aspirin as a promising agent for decreasing incidence of cerebral aneurysm rupture. Stroke 2011 ; 42 : 3156-62.
PubMed
19) Hasan DM, et al. Evidence that acetylsalicylic and attenuates inflammation in the walls of human cerebral aneurysms : Preliminary results. J Am Heart Assoc 2013 ; 2 : e000019.
 
20) Sato k, et al. Effect of inhalational anesthesia on cerebral circulation in Moyamoya desease. J Neurosurg Anesthesiol 1999 ; 11 : 25-30.
 
P.293 掲載の参考文献
1) Lisabeth LD, et al. Stroke risk after transient ischemic attack in a population-based setting. Stroke 2004 ; 35 : 1842-6.
 
2) Chandratheva A, et al. Population-based study of risk and predictors of stroke in the first few hours after a TIA. Neurology 2009 ; 72 : 1941-7.
PubMed
3) Wu CM, et al. Early risk of stroke after transient ischemic attack : A systematic review and meta-analysis. Arch Intern Med 2007 ; 167 : 2417-22.
PubMed
4) Rothwell PM, et al. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study) : A prospective population-based sequential comparison. Lancet 2007 ; 370 : 1432-42.
PubMed
5) Luengo-Fernadez R, et al. Effect of urgent treatment for transient ischaemic attack and minor stroke on disability and hospital costs (EXPRESS study) : A prospective population-based sequential comparison. Lancet Neurol 2009 ; 8 : 235-43.
 
6) 日本脳卒中学会 脳卒中ガイドライン [追補 2017] 委員会, 編. 脳卒中治療ガイドライン 2015 [追補 2017]. http://www.jsts.gr.jp/img/guideline2015_tuiho2017.pdf
 
7) Amarenco P, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006 ; 355 : 549-59.
 
8) Baigent C, et al. Efficacy and safety of more intensive lowering of LDL cholesterol : A meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 2010 ; 376 : 1670-81.
PubMed
9) Oates CP, et al. Joint recommendations for reporting carotid ultrasound investigations in the United Kingdom. Eur J Vasc Endovasc Surg 2009 ; 37 : 251-61.
PubMed
10) Yadav JS, et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004 ; 351 : 1493-501.
PubMed
11) Paulson OB, et al. Cerebral autoregulation. Cerebrovasc Brain Metab Rev 1990 ; 2 : 161-92.
PubMed
12) Cremer OL, et al. Long-term propofol infusion and cardiac failure in adult head-injured patients. Lancet 2001 ; 13 ; 357 : 117-8.
 
13) Petersen KD, et al. Intracranial pressure and cerebral hemodynamic in patients with cerebral tumors : A randomized prospective study of patients subjected to craniotomy in propofol-fentanyl, isoflurane-fentanyl, or sevoflurane-fentanyl anesthesia. Anesthesiology 2003 ; 98 : 329-36.
 
14) Leech P, et al. Intracranial volume--pressure relationships during experimental brain compression in primates. 2. Effect of induced changes in systematic arterial pressure and cerebral blood flow. J Neurol Neurosurg Psychatry 1974 ; 37 : 1099-104.
 
15) Albrecht RF, et al. Cerebral effects of extended hyperventilation in unanesthetized goats. Stroke 1987 ; 18 : 649-55.
PubMed
16) Hossmann KA. Resuscitation potentials after prolonged global cerebral ischemia in cats. Crit Care Med 1988 ; 16 : 964-71.
PubMed
17) Drummond JC, et al. Cerebral physiology and the effects of anesthetics and techniques. In : Miller RD, ed. Miller's Anesthesia. 5th ed. Philadelphia : Churchill Livingstone ; 2000, p.695-733.
 
18) Statler KD, et al. Isoflurane improves long-term neurologic outcome versus fentanyl after traumatic brain injury in rats. J Neurotrauma 2000 ; 17 : 1179-89.
PubMed
P.299 掲載の参考文献
1) Smith HW. The Kidney : Structure and Function in Health and Disease. New York : Oxford University Press ; 1951.
 
2) Bellomo R, et al. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs : The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004 ; 8 : R204-12.
PubMed
3) Mehta RL, et al. Acute Kidney Injury Network : Report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007 ; 11 : R31.
PubMed
4) Kellum JA, et al. Kidney Disease : Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl 2012 ; 2 : 1-138.
 
5) 濱野高行. AKI患者へのアプローチ. 深川雅史, ほか編. レジデントのための腎臓病診療マニュアル. 第2版. 東京 : 医学書院 ; 2012. p.201.
 
6) Yang L, et al. Acute kidney injury in China : A cross-sectional survey. Lancet 2015 ; 386 : 1465-71.
 
7) Kaddourah A, et al. Epidemiology of acute kidney injury in critically ill children and young adults. N Engl J Med 2017 ; 376 : 11-20.
 
8) 日本腎臓学会, 編. CKD診療ガイド 2012. 東京 : 東京医学社 ; 2012. p.100-28.
 
9) 宇田晋. 薬剤による腎障害. 深川雅史, ほか編. レジデントのための腎臓病診療マニュアル. 第2版. 東京 : 医学書院 ; 2012. p.416-20.
 
10) Myers BD, Moran SM. Hemodynamically mediated acute renal failure. N Engl J Med 1986 ; 314 : 97-105.
PubMed
11) Roizen MF, Fleisher LA. 合併疾患に対する麻酔の影響. 武田純三, 監修. 稲田英一, ほか監訳. ミラー麻酔科学. 原著第6版. 東京 : メディカル・サイエンス・インターナショナル ; 2007. p.795-893.
 
12) Cammu G, et al. Repeat dosing of rocuronium 1.2 mg kg-1 after reversal of neuromuscular block by sugammadex 4.0 mg kg-1 in anaesthetized healthy volunteers : A modelling-based pilot study. Br J Anaesth 2010 ; 105 : 487-92.
 
13) AKI (急性腎障害) 診療ガイドライン作成委員会, 編. AKI (急性腎障害) 診療ガイドライン 2016. 日腎会誌 2017 ; 59 : 419-533.
 
14) 加藤謙一. 腎障害と血液浄化療法. 三宅康史, 編. ICUハンドブック. 第2版. 東京 : 中外医学社 ; 2012. p.357-93.
 
P.303 掲載の参考文献
1) 吉田 明. 甲状腺疾患と女性の健康. 予防医学 2016 ; 58 : 57-61.
Medical*Online
2) Ross DS. Amiodarone and thyroid dysfunction. UpToDate?. https://www.uptodate.com/contents/amiodarone-and-thyroid-dysfunction
 
3) Fleisher LA, Mythen M. Anesthetic Implications of Concurrent Diseases. In : Miller RD, ed. Miller's Anesthesia. 8th ed. Philadelphia : Elsevier, Churchill Livingstone ; 2015. p.1156-225.
 
4) 水越常徳. 甲状腺・副甲状腺の内科的治療-バセドウ病ヨード併用療法. 北外誌 2016 ; 61 : 24-8.
 
5) Papi G, et al. Clinical concepts on thyroid emergencies. Front Endocrinol (Lausanne) 2014 ; 5 : 1-11.
 
6) Gurvitch DL. Thyrotoxicosis. In : Yao FSF, ed. Yao & Artusio's Anesthesiology : Problem-Oriented Patient Management. 6th ed. Philadelphia : Lippincott Williams & Wilkins, a Wolters Kluwer business ; 2008. p.753-66.
 
7) Ross DS. Thyroid storm. UpToDate?. https://www.uptodate.com/contents/thyroid-storm
 
8) Wall RT. Endocrine Disease. In : Hines RL, Marschall KE, eds. Stoelting's Anesthesia and Co-Existing Disease. 6th ed. Philadelphia : Elsevier Saunders ; 2012. p.376-406.
 
P.309 掲載の参考文献
1) Audibert F, et al. Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol 1996 ; 175 : 460-4.
PubMed
2) Sibai BM, et al. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 1993 ; 169 : 1000-6.
PubMed
3) Martin JN Jr, et al. Hellp syndrome and composite major maternal morbidity : Importance of Mississippi classification system. J Matern Fetal Neonatal Med 2013 ; 26 : 1201-6.
PubMed
4) 日本妊娠高血圧学会, 編. HELLP症候群・関連疾患. 妊娠高血圧症候群の診療指針 2015- Best Practice Guide. 東京 : メジカルビュー ; 2015. p.143-52.
 
5) 角倉弘行. 緊急帝王切開の緊急度分類と麻酔法の選択. 臨床麻酔 2012 ; 36 (臨増) : 333-43.
 
6) Wee MY, et al. The National Institute of Clinical Excellence (NICE) guidelines for caesarean sections : Implications for the anaesthetist. Int J Obstet Anesth 2005 ; 14 : 147-58.
PubMed
7) Gholitabar M, et al. Caesarean section : Summary of updated NICE guidance. BMJ 2011 ; 343 : d7108.
PubMed
8) del-Rio-Vellosillo M, Garcia-Medina JJ. Anesthetic considerations in HELLP syndrome. Acta Anaesthesiol Scand 2016 ; 60 : 144-57.
PubMed
9) Sumikura H, et al. Rethinking general anesthesia for cesarean section. J Anesth 2016 ; 30 : 268-73.
PubMed
10) Lee LO, et al. Risk of epidural hematoma after neuraxial techniques in thrombocytopenic parturients : A report from the Multicenter Perioperative Outcomes Group. Anesthesiology 2017 ; 126 : 1053-63.
PubMed
P.315 掲載の参考文献
1) Singer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016 ; 315 : 801-10.
PubMed
2) 西田修, ほか. 日本版敗血症診療ガイドライン 2016. http://www.jaam.jp/html/info/2016/pdf/J-SSCG2016_ver2.pdf
 
3) Chousterman BG, et al. Cytokine storm and sepsis disease pathogenesis. Semin Immunopathol 2017 ; 39 : 517-28.
PubMed
4) Rhodes A, et al. Surviving Sepsis Campaign : International Guidelines for Management of Sepsis and Septic Shock : 2016. Intensive Care Med 2017 ; 43 : 304-77.
PubMed
5) Eissa D, et al. Anaesthetic management of patients with severe sepsis. Br J Anaesth 2010 ; 105 : 734-43.
PubMed
6) Chen JP, et al. Expert consensus on the perioperative management of patients with sepsis. World J Emerg Med 2015 ; 6 : 245-60.
PubMed
7) Rivers E, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001 ; 345 (19) : 1368-77.
 
8) Loubani OM, Green RS. A systematic review of extravasation and local tissue injury from administration of vasopressors through peripheral intravenous catheters and central venous catheters. J Crit Care 2015 ; 30 : 653. e9-17.
 
9) 岡澤佑樹, ほか. 麻酔導入時の薬剤投与を契機に指摘し得た末梢挿入型中心静脈カテーテルの血管穿孔. 日本臨麻酔学会誌 2017 ; 37 : 172-5.
 
10) 日本集中治療医学会/日本呼吸療法医学会ARDS診療ガイドライン作成委員会. ARDS診療ガイドライン 2016. 日集中医誌 2017 ; 24 : 57-63.
 
11) Bratzler DW, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm 2013 ; 70 : 195-283.
 
12) Yamashita A, et al. Risk factors and prognosis of pain events during mechanical ventilation : A retrospective study. J Intensive Care 2017 ; 8 ; 5 : 17.
 
13) Barr J, et al. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med 2013 ; 41 : 263-306.
PubMed
14) 廣津聡子, ほか. 多尿を合併した敗血症性ショックの1例. 日集中医誌 2017 ; 24 : 49-50.
 
15) 佐和貞治. 敗血症に対する免疫調節経腸栄養の効果と多価不飽和脂肪酸生合成の栄養化学. 日集中医誌 2014 ; 21 : 127-9.
 
16) Finley A, Greenberg C. Heparin sensitivity and resistance : Management during cardiopulmonary bypass. Anesth Analg 2013 ; 116 : 1210-22.
PubMed
P.321 掲載の参考文献
1) 小嶋俊介, ほか. 溶血性輸血副作用. 臨床検査 2013 ; 57 : 876-83.
 
2) Cid J, et al. Low incidence of anti-D alloimmunization following D+ platelet transfusion : The Anti-D Alloimmunization after D-incompatible Platelet Transfusions (ADAPT) study. Br J Haematol 2015 ; 168 : 598-603.
PubMed
3) Gonzalez-Porras JR, et al. Prospective evaluation of a transfusion policy of D+ red blood cells into D-patients. Transfusion 2008 ; 48 : 1318-24.
PubMed
4) Pollack W, et al. Studies on Rh prophylaxis. 1. Relationship between doses of anti-Rh and size of antigenic stimulus. Transfusion 1971 ; 11 : 333-9.
 
5) Ayache S, Herman JH. Prevention of D sensitization after mismatched transfusion of blood components : Toward optimal use of RhIG. Transfusion 2008 ; 48 : 1990-9.
PubMed
P.327 掲載の参考文献
1) Horlocker TT, et al. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy : American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition). Reg Anesth Pain Med 2010 ; 35 : 64-101.
 
2) Narouze, et al. Interventional spine and pain procedures in patients on antiplatelet and anticoagulant medications : Guidelines from the American Society of Regional Anesthesia and Pain Medicine, the European Society of Regional Anaesthesia and Pain Therapy, the American Academy of Pain Medicine, the International Neuromodulation Society, the North American Neuromodulation Society, and the World Institute of Pain. Reg Anesth Pain Med 2015 ; 40 : 182-212.
 
3) Schultz NH, et al. The reversal effect of prothrombin complex concentrate (PCC), activated PCC and recombinant activated factor VII against anticoagulation of Xa inhibitor. Thromb J 2017 ; 15 : 6.
PubMed
4) Lankiewicz MW, et al. Urgent reversal of warfarin with prothrombin complex concentrate. J Thromb Haemost 2006 ; 4 : 967-70.
PubMed
5) Siegal DM, et al. Andexanet Alfa for the Reversal of Factor Xa Inhibitory Activity. N Engl J Med 2015 ; 373 : 2413-24.
 
P.333 掲載の参考文献
1) 竹内護, ほか. 血管抵抗に影響する因子. 竹内護, 森松博史, 監修. 改訂版 小児心臓麻酔マニュアル. 東京 : メディカルフロントインターナショナルリミテッド ; 2017. p.99.
 
2) Dalal PG, et al. Upper airway dimensions in children using rigid video-bronchoscopy and a computer software : Description of a measurement technique. Pediatr Anaesth 2008 ; 18 : 645-53.
 
3) Cote CJ. Pediatric anesthesia. In : Miller RD, ed. Miller's Anesthesia. 8th ed. Philadelphia : Elsevier Saunders ; 2015. p.2757-99.
 
4) Willis BA, et al. Rebreathing in a T-piece : Volunteer and theoretical studies of the Jackson-Rees modification of Ayre's T-piece during spontaneous respiration. Br J Anaesth 1975 ; 47 : 1239-46.
 
5) Davidson AJ, et al. Neurodevelopmental outcome at 2 years of age after general anaesthesia and awake-regional anaesthesia in infancy (GAS) : An international multicentre, randomised controlled trial. Lancet 2016 ; 387 : 239-50.
PubMed
6) Cote CJ, et al. Wasted ventilation measured in vitro with eight anesthetic circuits with and without inline humidification. Anesthesiology 1983 ; 59 : 442-6.
PubMed
7) 森田潔, ほか. 小児での使用. 武田純三, 編. ロクロニウムの基礎と臨床. 東京 : 真興交易医書出版 ; 2007. p.94-102.
 
8) Lupton BA, et al. Serum sodium concentration and intraventricular hemorrhage in premature infants. Am J Dis Child 1990 ; 144 : 1019-21.
PubMed

書評

最近チェックした商品履歴

Loading...